Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

NCT05060991 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Immunosuppression
Vaccine Response Impaired

Interventions

DRUG: Reduction in antimetabolite immunosuppression

Sponsor

University of California, Davis

Collaborators

[object Object]